Inventiva

$16.25
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.18 (+1.12%) Today
$0.00 (0.00%) As of 9:00 PM UTC after-hours

Why Robinhood?

You can watch Inventiva and buy or sell other stocks, options, and ETFs commission-free!

About IVA

Inventiva SA engages in the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis and related diseases. It owns an in-house drug-discovery platform that develops internal oncology and fibrosis discovery pipeline with approaches centred on transcription factors, epigenetics targets, and nuclear receptors. The company was founded by Pierre Broqua and Frédéric Cren on October 27, 2011 and is headquartered in Daix, France. The listed name for IVA is Inventiva S.A. American Depository Shares.

CEO
Frédéric Cren
Employees
88
Headquarters
Daix, Bourgogne-Franche-Comte
Founded
2011
Market Cap
576.44M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
31.39K
High Today
$16.65
Low Today
$15.44
Open Price
$16.00
Volume
21.60K
52 Week High
$17.25
52 Week Low
$9.01

Collections

You May Also Like

TFC
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure